'Indian ayurveda sector set to grow at 16% CAGR over next 5 years'

The Indian ayurveda industry comprising both ayurveda products (ethical, classical, OTC, personal care and beauty products) and services (medical, well-being, payor and medical tourism services) is estimated to be $3-bn and expected to grow at 16% CAGR in the next 5 years. This was revealed in a Confederation of Indian Industry (CII) report titled ‘Ayurveda industry – market size, strength and way forward’.
The report was released during the “2nd Ayurveda Conclave: Vision 2022: Roadmap to Achieve Three Times Growth in Market Size” on 2nd November, 2018, in New Delhi. The event saw the presence of representatives from both private and government sectors.
Speaking at the event, Dr. Naresh Trehan Chairman CII Healthcare Council and Chairman and MD Medanta-The Medicity, contextualised Ayurveda with respect to modern medicine. He emphasised that demystification of this ancient medicine system will pave the way for it to move ahead. “India can become an example to the world if it can fuse the power of modern and traditional
medicine which is possible through, rigorous research, documentation and evidence.”
Advocates of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy) have been keen on becoming a part of Ayushman Bharat post its announcement. In this context, Dr. Vinod Paul, Member, NITI Aayog reiterated Dr. Trehan’s point on demystification. “This will help build standard treatment guidelines that will ensure uniformity in treatment protocol across the states and its easy governance”. He added that the government is open to proposals but expects them to comply to current standards and regulations.
Mr. Rajiv Vasudevan, Chairman, CII Core Group of Ayurveda and CEO AyurVAID Hospital noted that unless Ayurveda is implemented in government initiatives such as Ayushman Bharat and National Nutrition Mission its true potential cannot be tapped.
Mr. Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, informed that the government has undertaken big initiatives to popularise Ayurveda in India as well as overseas. He mentioned that Ministry of Defence and Ministry of Labour have agreed to start AYUSH related services. Moreover, entry level accreditation by the National Accreditation Board for Hospitals has been initiated for AYUSH healthcare facilities that would help them procure soft loans. “A subsector skill council for AYUSH has been established for skilling of AYUSH professionals and MoUs with 15 countries have been signed with 13 more in the pipeline,” he added.
2026-09-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
$530 Million Lawsuit Unheard, $76 Million Counterclaim Filed: Is Qicai Chemical’s ‘Reputation Defense’ a Desperate Last Stand or a Calculated PR Gambit?
-
BASF Raises European NPG and HDO Prices by Up to €300/Tonne as Costs Climb
-
Rising Naphtha Prices in Japan Drive Up Costs for Diapers, Sanitary Products, and Cosmetics
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
-
Strait of Hormuz Reopens, Oil Prices Plunge: Is the Chemical Price Rally Over?
-
U.S. Chemical Companies Are Benefiting from This Feedstock Shock
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
Recommend Reading
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
Clean Food Group Secures UK, EU, and US Approval for Fermentation-Derived Cosmetic Oils
-
Celanese to Close Acetate Tow Plant in Lanaken, Belgium by 2026
-
NOVA Chemicals Launches PE Resins with Next-Generation Non-Fluoropolymer Processing Aid
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
Under a Triple Game, Polyethylene Operates with a Weak and Fluctuating Trend
-
Ammonium Sulfate Market Trend Weakens and Declines (10.23-10.29)
-
Supply Increases in Stages, China’s Acrylonitrile Market Slips Narrowly
-
October DMF Market Prices Weakly Decline
-
October Isopropyl Alcohol Market Price Rises First, Then Falls